Executive Profile

Earl M. Collier Jr.,J.D., Esq. Chief Executive Officer and Member of The Board of Directors, 480 Biomedical, Inc.

Age	Total Calculated Compensation	This person is connected to 5 Board Members in 5 different organizations across 11 different industries. See Board Relationships
64	--

Background

Mr. Earl M. Collier Jr., JD, Esq., Duke, serves as the Chief Executive Officer at Arsenal Vascular, Inc. (alternate name: Arsenal Medical Inc.). Mr. Collier serves as the Chief Executive Officer at 480 Biomedical, Inc. He has been Part-Time Senior Advisor at Genzyme Corporation since October 2009. He has been Executive Vice President of Cardiovascular & Oncology at Genzyme Biosurgery Corporation since August 2003. He has more than 30 years of experience in healthcare. ... He was a Senior Advisor at Polaris Partners. Previously, Mr. Collier served as Executive Vice President of the Genetics business at Genzyme Oncology, Inc. (alternate name: Genzyme Molecular Oncology) since January 2007, where he managed and built several of Genzyme's newer businesses, including its oncology and cardiovascular business units. During his tenure at Genzyme, Mr. Collier was responsible for building the biosurgery business and oversees the company's efforts in multiple sclerosis and other immune disorders. He served as Executive Vice President of Genzyme General. He served as Executive Vice President of Oncology and Cardiovascular businesses at Genzyme Tissue Repair and Genzyme Oncology, Inc. since August 2003. Mr. Collier joined Genzyme Corp. in January 1997 as a Senior Vice President of Health Systems and Genzyme Biosurgery Corporation from December 2000 to August 2003. Mr. Collier served as an outside Lawyer for Genzyme Corp. since 1990. Prior to joining the firm, he was the President of Vitas HealthCare Corporation from October 1991 to August 1995. Between 1981 and 1991, Mr. Collier was a Partner at Hogan and Hartson. Mr. Collier served as President of Genzyme Surgical Products from June 1999 to December 2000. He was also responsible for Genzyme Tissue Repair from December 1999 to December 2000. Mr. Collier was a Deputy Administrator for the Health Care Financing Administration in the Department of Health and Human Services during the Carter Administration. Mr. Collier was an Associate at Covington and Burlington law firm in Washington, D.C., from 1974 to 1977. He began his legal career in Washington as a clerk for the U.S. Court of Appeals. Mr. Collier sits on the Boards of Newton-Wellesley Hospital, Pervasis Therapeutics, Inc., and Beacon Hospice, and is a member of the Director’s Council of the MIT Center for Cancer Research. He serves as a Member of Board of Advisors of InCube Ventures, LLC and InCube Labs, LLC. He serves as a Director of MG Biotherapeutics LLC. He serves as a Director of 480 Biomedical, Inc. Mr. Collier served as a Director of Decode Genetics Inc. from July 18, 2006 to August 26, 2009. He served as a Director of Encorium Group Inc. from March 2002 to February 15, 2007. Mr. Collier was an Independent Director of Covalent Group Inc. from March 2002 to February 15, 2007. He earned a J.D. from the University of Virginia Law School and is an Esq. Mr. Collier holds a B.A. from Yale University.

Corporate Headquarters 480 Arsenal Street Watertown, Massachusetts 02172 United States Phone: 617-393-4600 Fax: -- Board Members Memberships Director Pervasis Therapeutics, Inc. Director MG Biotherapeutics LLC Chief Executive Officer and Member of The Board of Directors 480 Biomedical, Inc. 2002-2007 Former Director, Member of Audit Committee and Member of Compensation Committee Encorium Group Inc. 2006-2009 Former Director, Chairman of Compensation Committee and Member of Audit Committee DGI Resolution, Inc. Education BA Yale University JD University of Virginia School of Law Other Affiliations Polaris Partners DGI Resolution, Inc. Genzyme Tissue Repair Genzyme Corporation Encorium Group Inc. Genzyme Oncology, Inc. Genzyme Surgical Products Genzyme General Sanofi Biosurgery Yale University University of Virginia University of Virginia School of Law Pervasis Therapeutics, Inc. MG Biotherapeutics LLC InCube Ventures, LLC Arsenal Medical, Inc. InCube Labs, LLC

Annual Compensation There is no Annual Compensation data available. Stocks Options There is no Stock Options data available. Total Compensation There is no Total Compensation data available.

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.